The pulmonary vasculature has been frequently overlooked in acute and chronic lung
diseases, such as acute respiratory distress syndrome (ARDS), pulmonary fibrosis (PF), and …

Despite recent therapeutic advances, pulmonary hypertension (PH) remains a fatal disease
due to the development of right ventricular (RV) failure. At present, no treatments targeted at …

Background Pulmonary hypertension (PH) is a frequent complication in patients with COPD.
Objective To determine if, in patients with COPD, the presence of PH decreases exercise …

Pulmonary hypertension (PH) is a frequent and important complication of chronic obstructive
pulmonary disease (COPD). It is associated with worse clinical courses with more frequent …

In patients with chronic obstructive pulmonary disease (COPD), cardiovascular
comorbidities are highly prevalent and associated with considerable morbidity and mortality …

Pulmonary hypertension (PH) due to chronic obstructive pulmonary disease (COPD) is
classified as Group 3 PH, with no current proven targeted therapies. Studies suggest that …

Background Electronic cigarette (e-cigarette) vapour is gaining popularity as an alternative
to tobacco smoking and can induce acute lung injury. However, the specific role of nicotine …

Background Pulmonary hypertension (PH) is a common complication of chronic obstructive
pulmonary disease (COPD). However, it is unknown whether the ratio of forced vital capacity …

Objective To examine the risk of adverse cardiovascular (CV) events following an
exacerbation of chronic obstructive pulmonary disease (COPD). Methods This retrospective …

Background Pulmonary hypertension (PH) is a common complication of COPD, associated
with increased mortality and morbidity. Intriguingly, pulmonary vascular alterations have …